Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sylvia Lombardo"'
Autor:
WonHee Kim, Liang Ma, Selene Lomoio, Rachel Willen, Sylvia Lombardo, Jinghui Dong, Philip G. Haydon, Giuseppina Tesco
Publikováno v:
Molecular Neurodegeneration, Vol 13, Iss 1, Pp 1-22 (2018)
Abstract Background β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the rate-limiting enzyme in the production of amyloid beta (Aβ), the toxic peptide that accumulates in the brains of Alzheimer’s disease (AD) patients. Our previous
Externí odkaz:
https://doaj.org/article/7258624d78f2453a9df25d037112256f
Publikováno v:
Journal of Interprofessional Education & Practice. 31:100606
Autor:
WonHee Kim, Sylvia Lombardo, Giuseppina Tesco, Matthew E. Kennedy, Andrew J. Tarr, Thomas W. Rosahl, Philip G. Haydon, Tingyi Cao, Martina Chiacchiaretta, Griffin Sigal, Weiming Xia
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific Reports
Scientific Reports
BACE1 is the first enzyme involved in APP processing, thus it is a strong therapeutic target candidate for Alzheimer’s disease. The observation of deleterious phenotypes in BACE1 Knock-out (KO) mouse models (germline and conditional) raised some co
Autor:
Alexia Tiberi, Michael Cammer, Khalil Saadipour, Wilma J. Friedman, Moses V. Chao, John LaFrancois, Sylvia Lombardo, Francesca-Fang Liao, Noralyn B. Mañucat-Tan, Elena Grajales, Xin-Fu Zhou, Laura Ester Montroull, Helen E. Scharfman, Giueseppina Tesco, Paul M. Mathews
Publikováno v:
Mol Cell Neurosci
BACE1 is a transmembrane aspartic protease that cleaves various substrates and it is required for normal brain function. BACE1 expression is high during early development, but it is reduced in adulthood. Under conditions of stress and injury, BACE1 l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de0ee3339c7ccab47d89d781728ce19c
https://europepmc.org/articles/PMC6993608/
https://europepmc.org/articles/PMC6993608/
Publikováno v:
Neurobiology of Aging
Neurobiology of Aging, 2016, 46, pp.221-234. ⟨10.1016/j.neurobiolaging.2016.06.005⟩
Neurobiology of Aging, Elsevier, 2016, 46, pp.221-234. ⟨10.1016/j.neurobiolaging.2016.06.005⟩
Neurobiology of Aging, 2016, 46, pp.221-234. ⟨10.1016/j.neurobiolaging.2016.06.005⟩
Neurobiology of Aging, Elsevier, 2016, 46, pp.221-234. ⟨10.1016/j.neurobiolaging.2016.06.005⟩
International audience; Keywords: In vivo amyloid pathology Amyloid precursor protein a7 nicotinic receptor b2 nicotinic receptor Memory deficit Hippocampus a b s t r a c t Alzheimer's disease (AD) is characterized by the presence of plaques and tang
Autor:
Selene Lomoio, Sylvia Lombardo, WonHee Kim, Jinghui Dong, Giuseppina Tesco, Rachel Willen, Liang Ma, Philip G. Haydon
Publikováno v:
Molecular Neurodegeneration
Molecular Neurodegeneration, Vol 13, Iss 1, Pp 1-22 (2018)
Molecular Neurodegeneration, Vol 13, Iss 1, Pp 1-22 (2018)
Background β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the rate-limiting enzyme in the production of amyloid beta (Aβ), the toxic peptide that accumulates in the brains of Alzheimer’s disease (AD) patients. Our previous studies
Autor:
Ottavio Arancio, Nancy Bartolotti, Adam W. Bero, Jacqueline A. Bonds, Marcelo G. Bonini, Guojun Bu, Xu Chen, Toby Cumming, Jole Fiorito, Li Gan, David Gate, Walter Gulisano, Peter C. Hart, Jacob M. Haus, Katherine A. Jackman, Takahisa Kanekiyo, Orly Lazarov, Sylvia Lombardo, Robert A. Marr, Keri Martinowich, Eliezer Masliah, Alyson A. Miller, Richard D. Minshall, Russell Nicholls, Agostino Palmeri, Rosita Purgatorio, Daniela Puzzo, Amanda R. Rabinowitz, Meredith C. Reichert, David P. Salmon, Robert J. Schloesser, Douglas H. Smith, Giuseppina Tesco, Terrence Town, Li-Huei Tsai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f508e7bec2a61acbe6c081f6f466203b
https://doi.org/10.1016/b978-0-12-802851-3.00020-6
https://doi.org/10.1016/b978-0-12-802851-3.00020-6
Autor:
Giuseppina Tesco, Sylvia Lombardo
β-secretase has been identified as a novel membrane-tethered member of the aspartyl proteases, termed β-site APP cleaving enzyme 1 (BACE1). The generation of BACE1 null mice has clearly demonstrated that BACE1 is the limiting enzyme for Aβ generat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::105e614eecde050b1a56ae66b5a25788
https://doi.org/10.1016/b978-0-12-802851-3.00008-5
https://doi.org/10.1016/b978-0-12-802851-3.00008-5
Autor:
Uwe Maskos, Sylvia Lombardo
Publikováno v:
Neuropharmacology
Neuropharmacology, 2015, The Nicotinic Acetylcholine Receptor: From Molecular Biology to Cognition, 96 (Pt B), pp.255-62. ⟨10.1016/j.neuropharm.2014.11.018⟩
Neuropharmacology, Elsevier, 2015, The Nicotinic Acetylcholine Receptor: From Molecular Biology to Cognition, 96 (Pt B), pp.255-62. ⟨10.1016/j.neuropharm.2014.11.018⟩
Neuropharmacology, 2015, The Nicotinic Acetylcholine Receptor: From Molecular Biology to Cognition, 96 (Pt B), pp.255-62. ⟨10.1016/j.neuropharm.2014.11.018⟩
Neuropharmacology, Elsevier, 2015, The Nicotinic Acetylcholine Receptor: From Molecular Biology to Cognition, 96 (Pt B), pp.255-62. ⟨10.1016/j.neuropharm.2014.11.018⟩
International audience; Alzheimer's Disease (AD) is the major form of senile dementia, characterized by neuronal loss, extracellular deposits, and neurofibrillary tangles. It is accompanied by a loss of cholinergic tone, and acetylcholine (ACh) level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab51442e164f28cd059825162b2fe1f3
https://hal-pasteur.archives-ouvertes.fr/pasteur-01197130/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-01197130/document